Safety Rates Drug Report: MONTELUKAST SODIUM. Pulmonary function test decreased adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: MONTELUKAST SODIUM. Injury: Pulmonary function test decreased Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 8 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
123963613	MONTELUKAST SODIUM.	Pulmonary function test decreased	MERCK	45.00 YR	M	99 KG	20160920	DE
124091124	MONTELUKAST SODIUM.	Pulmonary function test decreased	SANDOZ	45.00 YR	M	99 KG	20160925	DE
124100654	MONTELUKAST SODIUM.	Pulmonary function test decreased	ROCHE	45.14 YR	M	0	20160929	DE
127632091	MONTELUKAST SODIUM.	Pulmonary function test decreased	MEDA	0.00	F	109 KG	20160920	US
127644171	MONTELUKAST SODIUM.	Pulmonary function test decreased	BOEHRINGER INGELHEIM	0.00	F	109 KG	20160920	US
127644371	MONTELUKAST SODIUM.	Pulmonary function test decreased	BOEHRINGER INGELHEIM	0.00	F	109 KG	20160920	US
127869141	MONTELUKAST SODIUM.	Pulmonary function test decreased	TEVA	0.00	F	109 KG	20160928	US
128006561	MONTELUKAST SODIUM.	Pulmonary function test decreased	BAUSCH AND LOMB	0.00	F	0	20160930	US

|< 1/2 << Previous Page Page 1

Total Records: 8 Number of Pages: 1

Execution Time: 0.014333009719849 seconds (ucode:5019621). Developed by: James D. Barger